Angiotensin II: A major regulator of subcutaneous adipose tissue blood flow in humans

Journal of Physiology

Volumn 571, Issue 2, 2006, Pages 451-460

  Goossens, G H ^a,b   McQuaid, S E ^b   Dennis, A L ^b   van Baak, M A ^a   Blaak, E E ^a   Frayn, K N ^b   Saris, W H M ^a   Karpe, F ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; XENON 133; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ENALAPRIL MALEATE; GLUCOSE; VASOACTIVE AGENT;

ADIPOSE TISSUE BLOOD FLOW; ADRENERGIC RECEPTOR BLOCKING; ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; SUBCUTANEOUS TISSUE; DRUG EFFECT; DRUG MECHANISM; HORMONE ACTION; HUMAN TISSUE; ORAL GLUCOSE TOLERANCE TEST; RECEPTOR BLOCKING; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADULT; ANGIOTENSIN II; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FASTING; FEMALE; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEPTIDYL-DIPEPTIDASE A; POSTPRANDIAL PERIOD; RECEPTOR, ANGIOTENSIN, TYPE 1; REGIONAL BLOOD FLOW;

EID: 33645952651     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.101352     Document Type: Article

References (38)

1. Ardilouze JL, Fielding BA, Currie JM, Frayn KN & Karpe F (2004 a). Nitric oxide and beta-adrenergic stimulation are major regulators of preprandial and postprandial subcutaneous adipose tissue blood flow in humans. Circulation 109, 47-52.
2. Ardilouze JL, Karpe F, Currie JM, Frayn KN & Fielding BA (2004 b). Subcutaneous adipose tissue blood flow varies between superior and inferior levels of the anterior abdominal wall. Int J Obes Relat Metab Disord 28, 228-233.
3. Blaak EE, van Baak MA, Kemerink GJ, Pakbiers MT, Heidendal GA & Saris WH (1995). Beta-adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese, and reduced-obese subjects. Metabolism 44, 183-187.
4. Bulow J, Astrup A, Christensen NJ & Kastrup J (1987). Blood flow in skin, subcutaneous adipose tissue and skeletal muscle in the forearm of normal man during an oral glucose load. Acta Physiol Scand 130, 657-661.
5. Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM et al. (1992). Adipose tissue metabolism in obesity: Lipase action in vivo before and after a mixed meal. Metabolism 41, 264-272.
6. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ et al. (2005). Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 115, 1092-1099.
7. Danser AH (1996). Local renin-angiotensin systems. Mol Cell Biochem 157, 211-216.
8. Dzau VJ (1988). Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77, I4-I13.
9. Evans K, Clark ML & Frayn KN (1999). Effects of an oral and intravenous fat load on adipose tissue and forearm lipid metabolism. Am J Physiol 276, E241-E248.
10. Frayn KN, Karpe F, Fielding BA, Macdonald IA & Coppack SW (2003). Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 27, 875-888.
11. de Gasparo M (2002). Angiotensin II and nitric oxide interaction. Heart Fail Rev 7, 347-358.
12. Gohlke P, Pees C & Unger T (1998). AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31, 349-355.
13. Goossens GH, Blaak EE, Saris WH & van Baak MA (2004). Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects. J Clin Endocrinol Metab 89, 2690-2696.
14. Goossens GH, Blaak EE & van Baak MA (2003). Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev 4, 43-55.
15. Harte A, McTernan P, Chetty R, Coppack S, Katz J, Smith S et al. (2005). Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation 111, 1954-1961.
16. Hollenberg NK (2002). AT 1 -receptor blockade and the kidney: Importance of non-ACE pathways in health and disease. J Hum Hypertens 16 (Suppl. 3), S59-S63.
17. Hollenberg NK, Fisher ND & Price DA (1998). Pathways for angiotensin II generation in intact human tissue: Evidence from comparative pharmacological interruption of the renin system. Hypertension 32, 387-392.
18. Jansson PA, Larsson A & Lonnroth PN (1998). Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus. Eur J Clin Invest 28, 813-818.
19. Karpe F, Fielding BA, Ardilouze JL, Ilic V, Macdonald IA & Frayn KN (2002 a). Effects of insulin on adipose tissue blood flow in man. J Physiol 540, 1087-1093.
20. Karpe F, Fielding BA, Ilic V, Macdonald IA, Summers LK & Frayn KN (2002 b). Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 51, 2467-2473.
21. Linz W, Wiemer G, Gohlke P, Unger T & Scholkens BA (1995). Contribution of kinins to the cardiovascular actions of angiotensin- converting enzyme inhibitors. Pharmacol Rev 47, 25-49.
22. Millet L, Barbe P, Lafontan M, Berlan M & Galitzky J (1998). Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue. J Appl Physiol 85, 181-188.
23. Phillips MI, Speakman EA & Kimura B (1993). Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 43, 1-20.
24. Samra JS, Frayn KN, Giddings JA, Clark ML & Macdonald IA (1995). Modification and validation of a commercially available portable detector for measurement of adipose tissue blood flow. Clin Physiol 15, 241-248.
25. Samra JS, Simpson EJ, Clark ML, Forster CD, Humphreys SM, Macdonald IA et al. (1996 a). Effects of adrenaline infusion on the interstitial environment of subcutaneous adipose tissue as studied by microdialysis. Clin Sci (Lond) 91, 425-430.
26. Samra JS, Simpson EJ, Clark ML, Forster CD, Humphreys SM, Macdonald IA et al. (1996 b). Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism. Am J Physiol 271, E834-E839.
27. Saris JJ, van Dijk MA, Kroon I, Schalekamp MA & Danser AH (2000). Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm. Hypertension 35, 764-768.
28. Schiffelers SL, Akkermans JA, Saris WH & Blaak EE (2003). Lipolytic and nutritive blood flow response to beta-adrenoceptor stimulation in situ in subcutaneous abdominal adipose tissue in obese men. Int J Obes Relat Metab Disord 27, 227-231.
29. Simonsen L, Bulow J, Astrup A, Madsen J & Christensen NJ (1990). Diet-induced changes in subcutaneous adipose tissue blood flow in man: effect of beta-adrenoceptor inhibition. Acta Physiol Scand 139, 341-346.
30. Simonsen L, Enevoldsen LH & Bulow J (2003). Determination of adipose tissue blood flow with local 133Xe clearance. Evaluation of a new labelling technique. Clin Physiol Funct Imaging 23, 320-323.
31. Siragy HM & Carey RM (1999). Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33, 1237-1242.
32. Summers LK, Samra JS, Humphreys SM, Morris RJ & Frayn KN (1996). Subcutaneous abdominal adipose tissue blood flow: Variation within and between subjects and relationship to obesity. Clin Sci (Lond) 91, 679-683.
33. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S et al. (1999). Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 104, 925-935.
34. Unger T & Gohlke P (1990). Tissue renin-angiotensin systems in the heart and vasculature: Possible involvement in the cardiovascular actions of converting enzyme inhibitors. Am J Cardiol 65, 3I-10I.
35. Urata H, Nishimura H & Ganten D (1996). Chymase-dependent angiotensin II forming systems in humans. Am J Hypertens 9, 277-284.
36. Waeber B & Brunner HR (1996). Cardiovascular hypertrophy: Role of angiotensin II and bradykinin. J Cardiovasc Pharmacol 27, S36-S40.
37. Wolny A, Clozel JP, Rein J, Mory P, Vogt P, Turino M et al. (1997). Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res 80, 219-227.
38. Yeh SY & Peterson RE (1965). Solubility of krypton and xenon in blood, protein solutions, and tissue homogenates. J Appl Physiol 20, 1041-1047.